|
1.
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006.
|
|
3.
|
Allavena P, Garlanda C, Borrello MG, Sica
A and Mantovani A: Pathways connecting inflammation and cancer.
Curr Opin Genet Dev. 18:3–10. 2008. View Article : Google Scholar
|
|
4.
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
|
6.
|
Shiao SL, Ganesan AP, Rugo HS and Coussens
LM: Immune microenvironments in solid tumours: new targets for
therapy. Genes Dev. 25:2559–2572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Aggarwal BB, Shishodia S, Sandur SK,
Pandey MK and Sethi G: Inflammation and cancer: how hot is the
link? Biochem Pharmacol. 72:1605–1621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Balkwill F: TNF-alpha in promotion and
progression of cancer. Cancer Metastasis Rev. 25:409–416. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Mocellin S, Marincola FM and Young HA:
Interleukin-10 and the immune response against cancer: a
counterpoint. J Leukoc Biol. 78:1043–1051. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ali S and Lazennec G: Chemokines: novel
targets for breast cancer metastasis. Cancer Metastasis Rev.
26:401–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Balkwill F: Chemokine biology in cancer.
Semin Immunol. 15:49–55. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Allavena P, Germano G, Marchesi F and
Mantovani A: Chemokines in cancer-related inflammation. Exp Cell
Res. 317:664–673. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Luker KE and Luker GD: Functions of CXCL12
and CXCR4 in breast cancer. Cancer Lett. 238:30–41. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Uygur B and Wu WS: SLUG promotes prostate
cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol
Cancer. 10:1392011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
|
|
18.
|
Denko NC, Fontana LA, Hudson KM, et al:
Investigating hypoxic tumor physiology through gene expression
patterns. Oncogene. 22:5907–5914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Schioppa T, Uranchimeg B, Saccani A, et
al: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp
Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Mehta SA, Christopherson KW,
Bhat-Nakshatri P, et al: Negative regulation of chemokine receptor
CXCR4 by tumor suppressor p53 in breast cancer cells: implications
of p53 mutation or isoform expression on breast cancer cell
invasion. Oncogene. 26:3329–3337. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Webster GA and Perkins ND: Transcriptional
cross-talk between NF-kappaB and p53. Mol Cell Biol. 19:3485–3495.
1999.PubMed/NCBI
|
|
22.
|
Xenaki G, Ontikatze T, Rajendran R, et al:
PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional
activity in hypoxia. Oncogene. 27:5785–5796. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Blagosklonny MV, An WG, Romanova LY,
Trepel J, Fojo T and Neckers L: p53 inhibits hypoxia-inducible
factor-stimulated transcription. J Biol Chem. 273:11995–11998.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
An WG, Kanekal M, Simon MC, Maltepe E,
Blagosklonny MV and Neckers LM: Stabilization of wild-type p53 by
hypoxia-inducible factor 1alpha. Nature. 392:405–408. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lee SK, Kim HJ, Kim JW and Lee JW: Steroid
receptor coactivator-1 and its family members differentially
regulate trans-activation by the tumor suppressor protein p53. Mol
Endocrinol. 13:1924–1933. 1999. View Article : Google Scholar
|
|
26.
|
Ruas JL, Poellinger L and Pereira T: Role
of CBP in regulating HIF-1-mediated activation of transcription. J
Cell Sci. 118:301–311. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Rajendran R, Garva R, Krstic-Demonacos M
and Demonacos C: Sirtuins: molecular traffic lights in the
crossroad of oxidative stress, chromatin remodeling, and
transcription. J Biomed Biotechnol. 2011:3682762011. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Xu J, Wu R-C and O’Malley BW: Normal and
cancer-related functions of the p160 steroid receptor co-activator
(SRC) family. Nat Rev Cancer. 9:615–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Onate SA, Tsai SY, Tsai MJ and O’Malley
BW: Sequence and characterization of a coactivator for the steroid
hormone receptor superfamily. Science. 270:1354–1357. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Demonacos C and La Thangue NB: Drug
discovery and the p53 family. Prog Cell Cycle Res. 5:375–382.
2003.PubMed/NCBI
|
|
31.
|
Keimling M and Wiesmuller L: DNA
double-strand break repair activities in mammary epithelial cells -
influence of endogenous p53 variants. Carcinogenesis. 30:1260–1268.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Carrero P, Okamoto K, Coumailleau P,
O’Brien S, Tanaka H and Poellinger L: Redox-regulated recruitment
of the transcriptional coactivators CREB-binding protein and SRC-1
to hypoxia-inducible factor 1alpha. Mol Cell Biol. 20:402–415.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Lavery DN and Bevan CL: Androgen receptor
signalling in prostate cancer: the functional consequences of
acetylation. J Biomed Biotechnol. 2011:8621252011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J
and Le AD: Resveratrol inhibits hypoxia-induced accumulation of
hypoxia-inducible factor-1alpha and VEGF expression in human tongue
squamous cell carcinoma and hepatoma cells. Mol Cancer Ther.
4:1465–1474. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Lim J-H, Lee Y-M, Chun Y-S, Chen J, Kim
J-E and Park J-W: Sirtuin 1 modulates cellular responses to hypoxia
by deacetylating hypoxia-inducible factor 1α. Mol Cell. 38:864–878.
2010.PubMed/NCBI
|
|
36.
|
De Nardo D and Latz E: NLRP3 inflammasomes
link inflammation and metabolic disease. Trends Immunol.
32:373–379. 2011.PubMed/NCBI
|
|
37.
|
Strober W and Fuss IJ: Proinflammatory
cytokines in the pathogenesis of inflammatory bowel diseases.
Gastroenterology. 140:1756–1767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Mantovani A, Marchesi F, Porta C, Sica A
and Allavena P: Inflammation and cancer: breast cancer as a
prototype. Breast. 16(Suppl 2): S27–S33. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Toi M, Bicknell R and Harris AL:
Inhibition of colon and breast carcinoma cell growth by
interleukin-4. Cancer Res. 52:275–279. 1992.PubMed/NCBI
|
|
40.
|
Murdoch C and Lewis CE: Macrophage
migration and gene expression in response to tumor hypoxia. Int J
Cancer. 117:701–708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Hussain SP and Harris CC: Inflammation and
cancer: an ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
